BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11258707)

  • 21. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
    Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
    Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.
    Bigi A; Beltrami E; Trinei M; Stendardo M; Pelicci PG; Giorgio M
    Oncogene; 2016 Sep; 35(39):5132-43. PubMed ID: 26973251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
    Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
    Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.
    Sewing A; Wiseman B; Lloyd AC; Land H
    Mol Cell Biol; 1997 Sep; 17(9):5588-97. PubMed ID: 9271434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells.
    Chen D; Heath V; O'Garra A; Johnston J; McMahon M
    J Immunol; 1999 Dec; 163(11):5796-805. PubMed ID: 10570262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228.
    Yu X; Guo ZS; Marcu MG; Neckers L; Nguyen DM; Chen GA; Schrump DS
    J Natl Cancer Inst; 2002 Apr; 94(7):504-13. PubMed ID: 11929951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperating oncogenes converge to regulate cyclin/cdk complexes.
    Lloyd AC; Obermüller F; Staddon S; Barth CF; McMahon M; Land H
    Genes Dev; 1997 Mar; 11(5):663-77. PubMed ID: 9119230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation and regulation of Raf by Akt (protein kinase B).
    Zimmermann S; Moelling K
    Science; 1999 Nov; 286(5445):1741-4. PubMed ID: 10576742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular adhesion regulates p53 protein levels in primary human keratinocytes.
    Nigro JM; Aldape KD; Hess SM; Tlsty TD
    Cancer Res; 1997 Sep; 57(17):3635-9. PubMed ID: 9288761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway.
    Todd C; Reynolds NJ
    Am J Pathol; 1998 Jul; 153(1):39-45. PubMed ID: 9665463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p38δ regulates p53 to control p21Cip1 expression in human epidermal keratinocytes.
    Saha K; Adhikary G; Kanade SR; Rorke EA; Eckert RL
    J Biol Chem; 2014 Apr; 289(16):11443-11453. PubMed ID: 24599959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control.
    Di Cunto F; Topley G; Calautti E; Hsiao J; Ong L; Seth PK; Dotto GP
    Science; 1998 May; 280(5366):1069-72. PubMed ID: 9582119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.
    St John LS; Sauter ER; Herlyn M; Litwin S; Adler-Storthz K
    Cancer Gene Ther; 2000 May; 7(5):749-56. PubMed ID: 10830722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.
    Missero C; Di Cunto F; Kiyokawa H; Koff A; Dotto GP
    Genes Dev; 1996 Dec; 10(23):3065-75. PubMed ID: 8957006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mitogen-activated protein kinase pathway mediates growth arrest or E1A-dependent apoptosis in SKBR3 human breast cancer cells.
    Blagosklonny MV
    Int J Cancer; 1998 Nov; 78(4):511-7. PubMed ID: 9797142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of Taxol-induced cell death are concentration dependent.
    Torres K; Horwitz SB
    Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.